Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Field Programmable Gate Array (FPGA) Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)

Published

on

New York, June 08, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Field Programmable Gate Array (FPGA) Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” – https://www.reportlinker.com/p06249265/?utm_source=GNW
Field programmable gate arrays (FPGAs) are integrated circuits having a programmable hardware fabric. Unlike ASICs or graphics processing units (GPUs), the circuitry inside an FPGA chip is not hard etched; it can be reprogrammed as required. This capability makes FPGAs a suitable alternative to ASICs, which require a long development time as well as a significant investment to design and fabricate.
The tech industry has been adopting FPGAs for machine learning and deep learning. In the last decade, Microsoft Research demonstrated one of the first use cases of AI on FPGAs as part of the company’s efforts to accelerate web searches. FPGAs provide a combination of programmability, speed, and flexibility delivering performance without high cost and complexity to develop custom application-specific integrated circuits (ASICs). Microsoft’s Bing search engine also uses FPGAs in production, indicating their value for deep learning applications. According to the company, Bing realized a 50% increase in throughput using FPGAs to accelerate search ranking.
FPGAs offer hardware customization with integrated AI and are able to be programmed for delivering behavior like an ASIC or a GPU. The reconfigurable, reprogrammable nature of an FPGA makes itself well suited for a rapidly evolving AI landscape, enabling designers to test algorithms quickly and get to market fast. FPGAs provide several advantages for deep learning applications and other AI workloads, including an enhanced performance with low latency and high throughput, efficiency considering value and cost, and low power consumption.
Over the last few years, the demand for portable devices increased rapidly. Hence, the semiconductor industry must limit the power consumption of chips. The ASIC/FPGA chip design industry is driven toward low power development due to the widespread use of devices that require maximum speed and minimal power consumption, such as 5G smartphones, smart wearables, and healthcare devices that generate data continuously.
The demand for data centers, artificial intelligence (AI), and machine learning (ML) across enterprises, government, and educational entities is witnessing exponential growth due to the COVID-19 pandemic. This growth is positively impacting the demand for FPGAs. It is expected to maintain the same pace until the end of 2022, helping spread the impact and importance of FPGAs in various end-user industries.

Key Market Trends

Increasing Demand for IoT to Drive the Market

Parallel execution is a key benefit of FPGAs, as a number of sensors, like humidity and temperature sensors, operate continuously. Since no time needs to be spent on looping and waiting for the delay, FPGAs tend to be more power-efficient for IoT.
According to the State of the IoT 2020 report, the number of IoT connection devices surpassed the number of non-IoT connection devices for the first time. Out of the 21.7 billion active connected devices worldwide, 11.7 billion (or 54%) were IoT device connections at the end of 2020. By 2025, this number is expected to be over 30 billion, nearly 4 IoT devices per person on average.
The demand for IoT is expected to increase even further during the forecast period, which signifies the growth in demand for semiconductors and other components. According to SEMI, the size of the semiconductor and sensor market for IoT devices is expected to reach USD 114.2 billion by 2025.
With the rapid increase in the number of IoT devices, chip requirement for building IoT devices is also expected to rise during the forecast period. Reducing energy consumption, combined with the miniaturization of chips, will be prioritized by manufacturers.
IoT promises to be a major driving force that would create significant innovation, facilitate new business models, and improve global society in multiple ways. Market vendors focus on developing FPGAs to integrate them into IoT devices and solutions. For instance, Intel FPGAs solutions, such as Intel Stratix 10, allow scalability and flexibility to address IoT requirements with inherent software and hardware programmability.

China to Drive the Market in Asia-Pacific

China has the world’s largest semiconductor market. China consumes more than half of all semiconductors annually, both for internal use and potential export. As a result, the rapid expansion of Chinese demand boosted the FPGA market. On the other hand, domestic Chinese producers can only meet about 30% of their needs. As a result, the Chinese government urged its national champions and leading digital enterprises to develop their domestic semiconductor manufacturing capabilities to rebalance China’s reliance on overseas semiconductor demand.
Moreover, 5G adoption is growing in momentum for both the network and device domains. According to the report published, Ericson mobility 5G subscriptions are estimated to reach 1 billion, two years earlier than 4G. Key factors include China’s earlier engagement with 5G, compared to 4G, along with the timely availability of devices from several vendors. The Chinese telecom sector experienced rapid expansion in recent years, and it is predicted to continue to do so until 2025. The industry’s development is primarily fueled by increased population, communication services, and smartphone use. Premium connectivity and content services in China account for the majority of the market growth in the country.
Furthermore, China is paving the way for the FPGA market to expand, as the country’s demand is growing due to its leading position in the global manufacturing of consumer electronics gadgets. China is the world’s largest manufacturing hub, producing 36% of the world’s electronics, including smartphones, computers, cloud servers, and telecom infrastructure, establishing the country as the global electronics supply chain’s most important node. The popularity of artificial intelligence (AI) in China opened up a new development potential for the Chinese consumer electronics market. Smart homes and IoT (Internet of Things) are likely to be a significant development potential for manufacturers of FPGA in the next decade.
The demand for FPGA in China is growing continuously, owing to the increasing application area and use of FPGA in the end-user industry. For example. China’s military UAV industry is robust and growing rapidly. Programmable Gate Arrays (FPGAs) alter the development of such UAV systems. FPGAs are used in high-level navigation control techniques, like path planning, Simultaneous Localization and Mapping (SLAM), and stereo vision, as well as safety-critical low-level activities, including system stability, state estimation, and peripheral interface. Furthermore, besides investigating FPGA usage in mission-critical functions, such as target tracking, communication, and obstacle avoidance.

Competitive Landscape

The nature of competition within the industry can be studied in two different segments. Mainly due to the economies of scale and nature of the product offerings, the market space remains highly contested, and the cost-volume metrics favor companies that operate with low-fixed costs. Some key players in the market are Xilinx, Achronix Semiconductor Corp., Intel Corporation, and Quicklogic Corporation, among others. Some key recent developments in the market include:

February 2022 – QuickLogic Corporation announced that its PolarPro 3 family of low-power, SRAM-based FPGAs were available to solve semiconductor supply availability challenges. This highly flexible family features power consumption as low as 55uA and a tiny footprint in small packages, as well as die options.
November 2021 – Xilinx launched Alveo U55C, its most powerful accelerator card, purpose-built for HPC and big data workloads. The new Alveo U55C card is the company’s most powerful Alveo accelerator card, offering the highest computer density and HBM capacity in the Alveo accelerator portfolio.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support
Read the full report: https://www.reportlinker.com/p06249265/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch

Published

on

clinical-trials-matching-software-market-projected-to-reach-$832.56-million-by-2030-–-exclusive-report-by-360iresearch

PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.

“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html

Continue Reading

Artificial Intelligence

RepTrak Announces 2024 Global RepTrak® 100 Report

Published

on

reptrak-announces-2024-global-reptrak-100-report

BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.

After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg

View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html

Continue Reading

Artificial Intelligence

Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost

Published

on

group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost

SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.

“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html

Continue Reading

Trending